Aspire Biopharma Holdings, Inc.

ASBP

ASBPAspire Biopharma Holdings, Inc. US flag

NASDAQ Capital Market

5.84

USD

-0.18

- -

673,772.00Market Cap

Income Statement (USD)

API Chat

	2022 Y	2023 Y	2024 Y	2025 Y
Sales/Revenue/Turnover	- -	- -	- -	- -
+ Sales & Services Revenue	- -	- -	- -	- -
- Cost of Revenue	- -	- -	- -	- -
+ Cost of Goods & Services	- -	- -	- -	- -
Gross Profit	- -	- -	- -	- -
+ Other Operating Income	- -	- -	- -	- -
- Operating Expenses	1	1	1	19
+ Selling, General & Admin	- -	1	1	18
+ Research & Development	- -	- -	- -	1
+ Other Operating Expense	- -	- -	- -	- -
Operating Income (Loss)	-1	-1	-1	-19
- Non-Operating (Income) Loss	- -	-6	- -	5
+ Interest Expense, Net	- -	-6	- -	9
+ Interest Expense	- -	- -	- -	9
- Interest Income	- -	6	1	- -
+ Other Non-Op (Income) Loss	- -	- -	1	-3
Pretax Income	-1	4	-1	-24
- Income Tax Expense (Benefit)	- -	- -	- -	- -
- (Income) Loss from Affiliates	- -	- -	- -	- -
Income (Loss) from Cont Ops	-1	4	-1	-24
- Net Extraordinary Losses (Gains)	- -	- -	- -	- -
+ Discontinued Operations	- -	- -	- -	- -
+ Extraord. & Accounting Changes	- -	- -	- -	- -
Income (Loss) Incl. MI	-1	4	-1	-24
- Minority Interest	- -	- -	- -	- -
Net Income, GAAP	-1	4	-1	-24
- Preferred Dividends	- -	- -	- -	- -
- Other Adjustments	- -	- -	- -	- -
Net Income Avail to Common, GAAP	-1	4	-1	-24
EBIT	-1	-1	-1	-19
EBITDA	-1	-1	-1	-19
EBITDA Margin (%)	- -	- -	- -	-312,016.95
EBITA	-1	-1	-1	-19
Gross Margin (%)	- -	- -	- -	-1.87
Operating Margin (%)	- -	- -	- -	-312,016.95
Profit Margin (%)	- -	- -	- -	-394,725.06
Sales per Employee	- -	- -	- -	- -
Dividend per Share	- -	- -	- -	- -
Depreciation Expense	- -	- -	- -	- -
Basic Weighted Avg Shares	- -	- -	- -	- -
Basic EPS, GAAP	-15.57	116.44	-34.17	-491.28
Basic EPS from Cont Ops	-15.57	116.44	-34.17	-491.28
Diluted Weighted Avg Shares	- -	- -	- -	- -
Diluted EPS, GAAP	-15.57	116.44	-34.17	-491.28
Diluted EPS from Cont Ops	-15.57	116.44	-34.17	-491.28

Balance Sheet (USD)

API Chat

	2022 Y	2023 Y	2024 Y	2025 Y
Total Current Assets	- -	- -	- -	1
+ Cash, Cash Equivalents & STI	- -	- -	- -	1
+ Cash & Cash Equivalents	- -	- -	- -	1
+ ST Investments	- -	- -	- -	- -
+ Accounts & Notes Receiv	- -	- -	- -	- -
+ Accounts Receivable, Net	- -	- -	- -	- -
+ Notes Receivable, Net	- -	- -	- -	- -
+ Loans Receivable, Net	- -	- -	- -	- -
+ Other Receivable, Net	- -	- -	- -	- -
+ Inventories	- -	- -	- -	- -
+ Raw Materials	- -	- -	- -	- -
+ Work In Process	- -	- -	- -	- -
+ Finished Goods	- -	- -	- -	- -
+ Inventory Adjustments	- -	- -	- -	- -
+ Other Inventory	- -	- -	- -	- -
+ Other ST Assets	- -	- -	- -	- -
+ Misc ST Assets	- -	- -	- -	- -
+ Prepaid Expenses	- -	- -	- -	- -
+ ST Derivative & Hedging Assets	- -	- -	- -	- -
+ ST Assets Held-for-Sale	- -	- -	- -	- -
+ ST Deferred Tax Assets	- -	- -	- -	- -
Total Noncurrent Assets	- -	- -	- -	- -
+ Property, Plant & Equip, Net	- -	- -	- -	- -
+ Property, Plant & Equip	- -	- -	- -	- -
- Accumulated Depreciation	- -	- -	- -	- -
+ LT Investments & Receivables	- -	- -	- -	- -
+ LT Investments	- -	- -	- -	- -
+ LT Receivables	- -	- -	- -	- -
+ Other LT Assets	- -	- -	- -	- -
+ Total Intangible Assets	5	5	- -	- -
+ Goodwill	- -	- -	- -	- -
+ Other Intangible Assets	5	5	- -	- -
+ LT Deferred Tax Assets	- -	- -	- -	- -
+ LT Derivative & Hedging Assets	- -	- -	- -	- -
+ Misc LT Assets	-5	-5	- -	- -
Total Assets	- -	- -	- -	1
+ Payables & Accruals	- -	- -	- -	2
+ Accounts Payable	- -	- -	- -	1
+ Accrued Taxes	- -	- -	- -	- -
+ Interest & Dividends Payable	- -	- -	- -	- -
+ Other Payables & Accruals	- -	- -	- -	1
+ ST Debt	- -	- -	1	5
+ ST Borrowings	- -	- -	1	5
+ ST Finance Leases	- -	- -	- -	- -
+ Other ST Liabilities	- -	- -	- -	- -
+ Deferred Revenue	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -
+ Misc ST Liabilities	- -	- -	- -	- -
Total Current Liabilities	- -	1	2	8
+ LT Debt	- -	- -	- -	- -
+ LT Borrowings	- -	- -	- -	- -
+ LT Finance Leases	- -	- -	- -	- -
+ Other LT Liabilities	- -	- -	- -	- -
+ Accrued Liabilities	- -	- -	- -	- -
+ Pension Liabilities	- -	- -	- -	- -
+ Deferred Revenue	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -
+ Misc LT Liabilities	- -	- -	- -	- -
Total Noncurrent Liabilities	- -	- -	- -	- -
Total Liabilities	- -	1	2	8
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -
+ Share Capital & APIC	1	1	1	21
+ Common Stock	- -	- -	- -	- -
+ Additional Paid in Capital	1	1	1	21
- Treasury Stock	- -	- -	- -	- -
+ Retained Earnings	-1	-1	-3	-27
+ Other Equity	- -	- -	- -	- -
Equity Before Minority Interest	- -	- -	-2	-6
+ Minority/Non Controlling Interest	- -	- -	- -	- -
Total Equity	- -	- -	-2	-6
Total Liabilities & Equity	- -	- -	- -	1
Shares Outstanding	- -	- -	- -	- -
Number of Employees	- -	- -	- -	- -
Capital Leases - Total	- -	- -	- -	- -
Net Debt	- -	- -	1	4
Net Debt to Equity	-21.69	-71.63	-82.02	-65.42
Tangible Common Equity Ratio	103.11	110.84	-1,040.68	-485.94
Current Ratio	0.15	0.09	0.09	0.17
Cash Conversion Cycle	- -	- -	- -	6,381.07

Cash Flow Statement (USD)

API Chat

	2022 Y	2023 Y	2024 Y	2025 Y
+ Net Income	-1	- -	-1	-24
+ Depreciation & Amortization	- -	- -	- -	- -
+ Non-Cash Items	- -	- -	- -	19
+ Stock-Based Compensation	- -	- -	- -	14
+ Deferred Income Taxes	- -	- -	- -	- -
+ Asset Impairment Charge	- -	- -	- -	- -
+ Other Non-Cash Adj	- -	- -	- -	5
+ Chg in Non-Cash Work Cap	- -	- -	1	1
+ (Inc) Dec in Accts Receiv	- -	- -	- -	- -
+ (Inc) Dec in Inventories	- -	- -	- -	- -
+ (Inc) Dec in Prepaid Assets	- -	- -	- -	- -
+ Inc (Dec) in Accts Payable	- -	- -	- -	1
+ Inc (Dec) in Other	- -	- -	1	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -
Cash from Operating Activities	- -	- -	- -	-5
+ Change in Fixed & Intang	- -	- -	- -	- -
+ Disp in Fixed & Intang	- -	- -	- -	- -
+ Disp of Fixed Prod Assets	- -	- -	- -	- -
+ Disp of Intangible Assets	- -	- -	- -	- -
+ Acq of Fixed & Intang	- -	- -	- -	- -
+ Acq of Fixed Prod Assets	- -	- -	- -	- -
+ Acq of Intangible Assets	- -	- -	- -	- -
+ Cash (Repurchase) of Equity	1	- -	- -	- -
+ Increase in Capital Stock	1	- -	- -	- -
+ Decrease in Capital Stock	- -	- -	- -	- -
+ Net Change in LT Investment	- -	- -	- -	- -
+ Dec in LT Investment	- -	- -	- -	- -
+ Inc in LT Investment	- -	- -	- -	- -
+ Net Cash From Acq & Div	- -	- -	- -	- -
+ Cash from Divestitures	- -	- -	- -	- -
+ Cash for Acq of Subs	- -	- -	- -	- -
+ Cash for JVs	- -	- -	- -	- -
+ Other Investing Activities	-5	- -	- -	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -
Cash from Investing Activities	-5	- -	- -	- -
+ Dividends Paid	- -	- -	- -	- -
+ Net Cash From Debt	- -	- -	- -	7
+ Cash From Debt	- -	- -	- -	10
+ Repayments of Debt	- -	- -	- -	-4
+ Other Financing Activities	4	- -	- -	-1
+ Net Cash From Disc Ops	- -	- -	- -	- -
Cash from Financing Activities	5	- -	- -	6
Effect of Foreign Exchange Rates	- -	- -	- -	- -
Net Changes in Cash	- -	- -	- -	1
EBITDA	-1	-1	-1	-19
EBITDA Margin (%)	- -	- -	- -	-312,016.95
Free Cash Flow	- -	- -	- -	-5
Net Cash Paid for Acquisitions	- -	- -	- -	- -
Free Cash Flow to Firm	- -	- -	- -	- -
Free Cash Flow to Equity	- -	- -	- -	2
Free Cash Flow per Basic Share	-3.73	0.29	-6.92	-98.8
Price/Free Cash Flow	-110.53	1,499.68	-66.5	-0.05
Cash Flow to Net Income	0.24	- -	0.2	0.2
Capital Expenditures	- -	- -	- -	- -